OIM
NVAX icon

Oracle Investment Management’s Novavax NVAX Stock Holding History

Oracle Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-635,000
Closed -$5.51M – 25
2025
Q3 		$5.51M Buy
+635,000
New +$4.94M 3.44% 4
2025
Q1 		– Sell
-466,000
Closed -$3.75M – 20
2024
Q4 		$3.75M Sell
466,000
-68,600
-13% -$661K 2.04% 9
2024
Q3 		$6.75M Buy
+534,600
New +$6.9M 4.05% 7

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oracle Investment Management's NVAX Position: Q4 2025 in Review

Oracle Investment Management sold out of Novavax (NVAX) in Q4 2025, closing a stake of 243,000 shares — an estimated $2.11M sold.

Oracle Investment Management first reported a position in NVAX in Q3 2025 and held it in 1 quarter. The position peaked at $2.11M in Q3 2025. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Oracle Investment Management reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • Oracle Investment Management sold 243,000 Novavax shares in Q4 2025, an estimated $2.11M.
  • Oracle Investment Management first reported a position in Novavax in Q3 2025 and held it in 1 quarter.
  • Oracle Investment Management's Novavax position peaked at $2.11M in Q3 2025.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Oracle Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.